Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.

Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS. Expert Rev Neurother. 2004 Jul; 4(4):571-80.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.